References
- Cannom DS, Prystowsky EN. The evolution of the implantable cardioverter defibrillator. Naspe History Series. Pacing Clin. Electrophysiol 27(3), 419–431 (2004).
- American Heart Association. Heart Disease and Stroke Statistics —2004 Update. American Heart Association, TX, USA (2004).
- The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J. Med. 337, 1576–1583 (1997).
- Domanski MJ, Sakseena S, Epstein AE. Relative effectiveness of the implantable cardioverter defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J. Am. Coll. Cardiol 34,1090–1095 (1999).
- Sheldon R, Connolly S, Krahn A et al Identification of patients most likely to benefit from implantable cardioverter defibrillator therapy. The Canadian Implantable Defibrillator Study. Circulation 101,1660–1664 (2000).
- Kuck K-H, Cappato R, Siebels J et al Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study Hamburg (CASH). Circulation 102,748–754 (2000).
- Ezekowtiz JA, Armbstron PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann. Intern. Med. 138,445–452 (2003).
- Gallagher EJ, Lombardi G, Gennis E Effectiveness of bystander cardiopulmonary resuscitation and survival following out-of-hospital cardiac arrest. J. Am. Med. Assoc. 274,1922–1925 (1995).
- Becker LB, Ostrander MP, Barrett J, Kondos GT. Outcome of CPR in a large metropolitan area— where are the survivors? Ann. Emerg. Med. 20,355–361 (1991).
- Moss AJ, Hall WJ, Cannom DS et al Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J. Med. 335, 1933–1940 (1996).
- Buxton AE, Lee KL, Fisher JD et al A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl. J. Med. 341, 1882–1890 (1999).
- Buxton AE, Lee KL, DiCarlo L et al Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. N Engl. J. Med. 342,1937–1945 (2000).
- Wilber DJ, Olshansky B, Moran JF et al Electrophysiological testing and nonsustained ventricular tachycardia: use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 82,350–358 (1990).
- Singh SN, Fletcher RD, Fisher SG et al Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J. Med. 333,77–82 (1995).
- Moss AJ, Zareba W, Hall WJ et al Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl. J. Med. 346,877–883 (2002).
- Greenberg H, Case RB, Moss AJ et al Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J. Am. Coll. CardioL 43,1459–1465 (2004).
- Moss A. Madit II: substudies and their implications. Cardiac Electrophys. Rev. 7, 430–433 (2004).
- Gregoratos G, Abrams J, Kerber RE et al ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices. Circulation 106,2145–2161 (2002).
- Wilber DJ, Zareba W, Hall WJ. Time dependence of mortality risk defibrillator benefit after myocardial infarction. Circulation 109,1082–1084 (2004).
- Strickberger SA, Hummel JD, Bartlett TG. Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia — AMIOVIRT. Am. Coll. CardioL 41, 1707–1712 (2003).
- Bansch D, Antz M, Boczor S et al Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial. Circulation 105,1453–1448 (2002).
- Kadish A, Dyer A, Daub ert JP et al Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J. Med. 350, 2151–2158 (2004).
- Bristow MR, Saxon LA, Boehmer J et al Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl. J. Med. 350,2140–2150 (2004).
- La Rovere MT, Pinna GD, Hohnloser SH et al Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Implications for clinical trials. Circulation 103,2072–2077 (2001).
- Cohen RJ. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T wave alternans testing to risk stratify the MADIT II population. Cardiac Electrophys. Rev. 7, 438–442 (2003).
- Hohnloser SH, Ikeda T, Bloomfield DM, Dabbous OH, Cohen RJ. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362, 125–126 (2003).
- Grimm W, Christ M, Bach J et al Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy. Circulation 108,2883–2891 (2003).
Websites
- Annual Scientific Session Online. March 7–10, LA, USA (2004) Connolly SJ, Hohnloser SF, for the DINAMIT steering committee and investigators. The Defibrillator in Acute Myocardial Infarction Trial www.acc04online.acc.org (Accessed June 2004)
- Annual Scientific Session Online. March 7–10, LA, USA (2004) Bardy GH, Lee KL, Mark DB et al SCD-HeFT: Sudden Cardiac Death — HEart Failure Trial www.acc04online.acc.org (Accessed June 2004)